Quantcast

Latest HIV vaccine Stories

2014-10-22 08:33:24

IRVINE, Calif., Oct 22, 2014 /PRNewswire/ -- Antigen Discovery Inc. (ADi), a privately held company in Irvine, California, announced the receipt of a National Institutes of Health (NIH) Phase I Small Business Innovation Research award (SBIR) from the National Institute of Dental and Craniofacial Research (NIDCR). The one-year $225,000 award will fund the development of a Pan-HIV Protein Microarray Chip, which will contain every protein in all of the HIV-1 and HIV-2 subtypes and aid in...

2014-09-30 20:22:55

SILVERTHORNE, Colo., Sept. 30, 2014 /PRNewswire-USNewswire/ -- Keystone Symposia will convene the first conference of its 2014-2015 season and the first in its 2014-15 Global Health Series - on "The Modes of Action of Vaccine Adjuvants" at the Sheraton Seattle Hotel - immediately following the conclusion of the Grand Challenges Meeting for that program's grantees. The four-day conference is part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates...

2014-09-29 20:23:14

SEOUL, Republic Of Korea, Sept. 29, 2014 /PRNewswire/ -- The International Vaccine Institute (IVI), a Seoul-based non-profit international organization devoted to research in vaccine development and delivery for the developing world, announced the appointment of Jerome H. Kim, M.D., as the organization's Director General, effective early 2015. http://photos.prnewswire.com/prnvar/20140929/148946 "Jerome's scientific knowledge, technical expertise, and organizational and leadership...

2014-09-24 08:27:26

PLYMOUTH MEETING, Pa., Sept. 24, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced it will advance its DNA vaccine for Ebola into a phase I clinical trial in a collaboration with GeneOne Life Science Inc. (KSE: 011000), an international DNA vaccine manufacturer in which Inovio holds a minority interest. In the collaboration Inovio and GeneOne will co-develop Inovio's DNA-based Ebola vaccine through a phase I clinical trial. The companies are currently...

2014-09-18 08:20:30

PLYMOUTH MEETING, Pa., Sept. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today CEO Dr. J. Joseph Kim will be presenting at two upcoming investor conferences in New York, NY: Biocentury's NewsMakers in the Biotech Industry Conference and Bernstein's Genes as Drugs Event. NewsMakers in the Biotech IndustrySeptember 26, 20142:30 PM ETInvestor Presentation Bernstein's Genes as DrugsOctober 7, 20141:00 PM ETThis presentation will not be webcasted....

2014-09-03 08:33:41

PLYMOUTH MEETING, Pa., Sept. 3, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Inovio will present at the upcoming Rodman and Renshaw Investment Conference in New York, NY and at the Aegis Capital Healthcare and Technology Conference in Las Vegas, NV. Dr. J. Joseph Kim, Inovio's Chief Executive Officer, will provide a corporate overview of the Company and its programs at each of these events. Rodman & Renshaw Investment Conference September...

2014-08-01 08:26:14

PLYMOUTH MEETING, Pa., Aug. 1, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call to report its second quarter 2014 financial results on Monday, August 11, 2014 at 9:00 AM ET. CEO Dr. J. Joseph Kim and CFO Peter Kies will discuss second quarter earnings, provide a corporate update, and participate in a live Q&A with analysts. The update will include clinical development plans for VGX-3100, Inovio's immune therapy...

2014-07-23 12:31:13

MELBOURNE, Australia, July 23, 2014 /CNW/ - The Honourable Rona Ambrose, Minister of Health, participated in the 20(th) International AIDS Conference this week in Melbourne, Australia. During the Conference sessions, meetings and side events, Minister Ambrose reinforced Canada's continued commitment to global efforts to address HIV/AIDS and to advancing a comprehensive and integrated long-term approach to address HIV/AIDS in Canada. While in Melbourne, Minister Ambrose toured the...

2014-07-01 04:21:59

Inovio Shares Enter No. 1 U.S. Equity Index for Asset Benchmarking PLYMOUTH MEETING, Pa., July 1, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced that it has been added to the Russell Global, Russell 2000 and Russell Microcap Indexes. Each June, Russell realigns its family of global equity indexes to reflect market changes in the past year. Approximately $5.2 trillion in assets are currently benchmarked to Russell Indexes. Many investors use mutual funds...

2014-06-24 10:58:46

Monash University Huge advancements have taken place in HIV treatment and prevention over the past 10 years, but there is still no cure or vaccine. The findings are part of a review into the global HIV epidemic published in The Lancet, co-authored by Monash University Professor Sharon Lewin. The review shows that because of advancements in treatment, people with the virus are living longer. Overall, new infections have decreased from 3.3 million in 2002 to 2.3 million in 2012....


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin